These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 31042321)

  • 1. A left atrial appendage closure combined procedure review: Past, present, and future perspectives.
    Gasperetti A; Fassini G; Tundo F; Zucchetti M; Dessanai M; Tondo C
    J Cardiovasc Electrophysiol; 2019 Aug; 30(8):1345-1351. PubMed ID: 31042321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Left atrial appendage closure: A therapy uniquely suited for specific populations of patients with atrial fibrillation.
    Black-Maier E; Piccini JP; Granger CB
    J Cardiovasc Electrophysiol; 2019 Dec; 30(12):2968-2976. PubMed ID: 31520437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic review on left atrial appendage closure with the LAmbre device in patients with non-valvular atrial fibrillation.
    Ali M; Rigopoulos AG; Mammadov M; Torky A; Auer A; Matiakis M; Abate E; Bakogiannis C; Tzikas S; Bigalke B; Sedding D; Noutsias M
    BMC Cardiovasc Disord; 2020 Feb; 20(1):78. PubMed ID: 32050904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An under-recognized high-risk atrial fibrillation population: Analyzing transcatheter mitral valve repair patients for left atrial appendage closure device application.
    Lane CE; Eleid MF; Holmes DR
    Catheter Cardiovasc Interv; 2019 Aug; 94(2):274-279. PubMed ID: 30953408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Left Atrial Appendage: Target for Stroke Reduction in Atrial Fibrillation.
    Ramlawi B; Abu Saleh WK; Edgerton J
    Methodist Debakey Cardiovasc J; 2015; 11(2):100-3. PubMed ID: 26306127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left atrial catheter ablation in patients with previously implanted left atrial appendage closure devices.
    Wintgens LIS; Klaver MN; Swaans MJ; Alipour A; Balt JC; van Dijk VF; Rensing BJWM; Wijffels MCEF; Boersma LVA
    Europace; 2019 Mar; 21(3):428-433. PubMed ID: 30380015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Residual flow may increase the risk of adverse events in patients received combined catheter ablation and transcatheter left atrial appendage closure for nonvalvular atrial fibrillation: a meta-analysis.
    Han Z; Wu X; Chen Z; Ji W; Liu X; Liu Y; Di W; Li X; Yu H; Zhang X; Xu B; Lan RF; Xu W
    BMC Cardiovasc Disord; 2019 Jun; 19(1):138. PubMed ID: 31182014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Propensity-Matched Comparison of Oral Anticoagulation Versus Antiplatelet Therapy After Left Atrial Appendage Closure With WATCHMAN.
    Søndergaard L; Wong YH; Reddy VY; Boersma LVA; Bergmann MW; Doshi S; Kar S; Sievert H; Wehrenberg S; Stein K; Holmes DR
    JACC Cardiovasc Interv; 2019 Jun; 12(11):1055-1063. PubMed ID: 31171282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of atrial fibrillation: a comprehensive review and practice guide.
    Li J; Gao M; Zhang M; Liu D; Li Z; Du J; Hou Y
    Cardiovasc J Afr; 2020 May/Jun 23; 31(3):153-158. PubMed ID: 32186324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left atrial appendage closure.
    Lin AC; Knight BP
    Prog Cardiovasc Dis; 2015; 58(2):195-201. PubMed ID: 26241302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An overview of current and emerging devices for percutaneous left atrial appendage closure.
    Chow DHF; Wong YH; Park JW; Lam YY; De Potter T; Rodés-Cabau J; Asmarats L; Sandri M; Sideris E; McCaw T; Lee RJ; Sievert H; Søndergaard L; De Backer O
    Trends Cardiovasc Med; 2019 May; 29(4):228-236. PubMed ID: 30205924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thromboembolic events and need for anticoagulation therapy following left atrial appendage occlusion in patients with electrical isolation of the appendage.
    Gadiyaram VK; Mohanty S; Gianni C; Trivedi C; Al-Ahmad A; Burkhardt DJ; Gallinghouse JG; Hranitzky PM; Horton RP; Sanchez JE; Della Rocca DG; Di Biase L; Price MJ; Couts L; Gibson D; Natale A
    J Cardiovasc Electrophysiol; 2019 Apr; 30(4):511-516. PubMed ID: 30623500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Device-Related Thrombus After Left Atrial Appendage Closure: Incidence, Predictors, and Outcomes.
    Dukkipati SR; Kar S; Holmes DR; Doshi SK; Swarup V; Gibson DN; Maini B; Gordon NT; Main ML; Reddy VY
    Circulation; 2018 Aug; 138(9):874-885. PubMed ID: 29752398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The budget impact of left atrial appendage closure compared with adjusted-dose warfarin and dabigatran etexilate for stroke prevention in atrial fibrillation.
    Amorosi SL; Armstrong S; Da Deppo L; Garfield S; Stein K
    Europace; 2014 Aug; 16(8):1131-6. PubMed ID: 24687964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late clinical outcomes of lambre versus amplatzer occluders for left atrial appendage closure.
    Schnupp S; Liu XX; Buffle E; Gloekler S; Mohrez Y; Cheikh-Ibrahim M; Allakkis W; Brachmann J; Park JW; Kleinecke C
    J Cardiovasc Electrophysiol; 2020 Apr; 31(4):934-942. PubMed ID: 32072692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and Safety of Left Atrial Appendage Closure With WATCHMAN in Japanese Nonvalvular Atrial Fibrillation Patients　- Final 2-Year Follow-up Outcome Data From the SALUTE Trial.
    Aonuma K; Yamasaki H; Nakamura M; Matsumoto T; Takayama M; Ando K; Hirao K; Goya M; Morino Y; Hayashida K; Kusano K; Gomi Y; Main ML; Uchida T; Saito S
    Circ J; 2020 Jul; 84(8):1237-1243. PubMed ID: 32595176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonvalvular atrial fibrillation in high-hemorrhagic-risk patients: state of the art of percutaneous left atrial appendage occlusion.
    Merella P; Lorenzoni G; Marziliano N; Berne P; Viola G; Pischedda P; Casu G
    J Cardiovasc Med (Hagerstown); 2019 Jan; 20(1):1-9. PubMed ID: 30431481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety profiles of percutaneous left atrial appendage closure devices: An analysis of the Food and Drug Administration Manufacturer and User Facility Device Experience (MAUDE) database from 2009 to 2016.
    Jazayeri MA; Vuddanda V; Turagam MK; Parikh V; Lavu M; Atkins D; Earnest M; Di Biase L; Natale A; Wilber D; Reddy YM; Lakkireddy DR
    J Cardiovasc Electrophysiol; 2018 Jan; 29(1):5-13. PubMed ID: 28988455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous Left Atrial Appendage Closure: Current Devices and Clinical Outcomes.
    Asmarats L; Rodés-Cabau J
    Circ Cardiovasc Interv; 2017 Nov; 10(11):. PubMed ID: 29146668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel stroke risk reduction in atrial fibrillation: left atrial appendage occlusion with a focus on the Watchman closure device.
    Alipour A; Wintgens LI; Swaans MJ; Balt JC; Rensing BJ; Boersma LV
    Vasc Health Risk Manag; 2017; 13():81-90. PubMed ID: 28293114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.